Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

ERVA ÖZKAN

Doktor Öğretim Üyesi

Ankara Medipol Üniversitesi

Research topics OpenAlex
Articles 28 YÖKSİS 22 · OpenAlex 6 Total citations 302 h-index 10 · OpenAlex OpenAlex coverage %100 matched 25 / 25 Q1 articles 6 Scopus · WoS Q1 5 Co-authors 17 4 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 25 + YÖKSİS · co-author record: 1
h-index 10 Percentile in Türkiye: 84 #34 of 311 at their university by h-index
i10-index
11
Total citations
302
Top 20% in Türkiye
Per article
11.6
FWCI
1.64
1.00 = world average
World top 1%
0
World top 10%
4

Most cited articles

  1. Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer 2022 world top 10% 52 citations
  2. Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage 2020 42 citations
  3. Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells 2023 world top 10% 24 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (24 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 11.

Citing publications Crossref 22 publications citing 28 DOI-bearing articles · 3 Türkiye-affiliated
  • 2020 2
  • 2021 10
  • 2022 3
  • 2025 6
  • 2026 1
  1. DOI 10.1016/j.aaf.2025.11.005 2026
  2. Computational insights into the binding interactions of natural compounds with Varroa destructor targets TR Faik Gökalp · International Journal of Biological Macromolecules · 2025
  3. Multifaceted anticancer activity of nafamostat mesylate in human fibrosarcoma: first evidence of mitochondrial apoptosis and suppressed MMP-2/-9 mRNA expression TR Cafer Yildirim et al. · BMC Pharmacology and Toxicology · 2025
  4. DOI 10.3390/ph18121859 2025
  5. DOI 10.1007/s44446-025-00052-0 2025
  6. DOI 10.3390/cancers17213519 2025
  7. DOI 10.1080/03043797.2025.2576606 2025
  8. YENİ NESİL LİPİT BAZLI İLAÇ TAŞIYICI SİSTEMLER: LİPİT NANOKAPSÜLLER TR Hatice DEMİRTAŞ et al. · Ankara Universitesi Eczacilik Fakultesi Dergisi · 2022
  9. DOI 10.31083/j.fbl2702071 2022
  10. DOI 10.1016/j.colcom.2021.100570 2022
  11. DOI 10.1016/j.jddst.2020.102102 2021
  12. DOI 10.4155/fmc-2020-0309 2021
  13. DOI 10.2147/cmar.s320193 2021
  14. DOI 10.1111/jfbc.13910 2021
  15. DOI 10.1016/j.jfluchem.2021.109879 2021
  16. DOI 10.1186/s12935-021-02345-5 2021
  17. DOI 10.1016/j.etap.2020.103542 2021
  18. DOI 10.1080/87559129.2021.2003380 2021
  19. DOI 10.1002/ptr.7095 2021
  20. DOI 10.3390/ph14040372 2021
  21. DOI 10.1016/j.biopha.2020.110695 2020
  22. DOI 10.1007/s00706-020-02693-4 2020
Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 18.4% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Works 28

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 2 articles
OpenAlex citation percentile
Top 1%0
Top 10%4
Avg · n 24 %69.7
Other counts

Scopus (SJR)

  • YÖKSİS rows 20

WoS (JCR)

  • YÖKSİS rows 19

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

28articles

Journals with publications

21 journals

Narrow down

Scopus (SJR)
Q16 Q210 Q34 Q40
WoS (JCR)
Q15 Q27 Q36 Q41
TR Index
2articles

Article list

  1. 2026 Structure‐Guided Optimization and Biological Validation of 1,3,4‐Thiadiazole‐Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions Drug Development Research DOI 10.1002/ddr.70256 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 97.5%
  2. 2026 The iron fist of nature: Cannabinoid derivatives alter iron homeostasis and activate ferroptotic pathways in glioblastoma cells The Journal of Pharmacology and Experimental Therapeutics DOI 10.1016/j.jpet.2026.104319 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.1%
  3. 2025 Targeting SIRT2 with Oxadiazole/Thiadiazole-Based Acetamides: In Silico Screening and In Vitro Cytotoxicity Evaluation Polycyclic Aromatic Compounds DOI 10.1080/10406638.2025.2562259 YÖKSİS SJR Q3 JCR Q2 OpenAlex 69.0%
  4. 2025 In silico approach reveals N-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2023.2293252 YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.7%
  5. 2025 Rewiring chemotherapy response: venetoclax sensitizes human lung cancer cells to etoposide via enhanced DNA damage and ferroptotic pathways Anatolian Current Medical Journal DOI 10.38053/acmj.1786765 YÖKSİS TR Index OpenAlex 35.4%
  6. 2025 Time-dependent exposure to venetoclax induces ferroptosis in human neuroblastoma cells via upregulated transferrin gene expression and lipid peroxidation Annals of Medical Research DOI 10.5455/annalsmedres.2025.07.192 YÖKSİS TR Index OpenAlex 59.0%
  7. 2024 2‐(Methyl(phenyl)amino)‐N‐(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition Drug Development Research DOI 10.1002/ddr.22224 YÖKSİS SJR Q2 JCR Q1 OpenAlex 73.2%
  8. 2024 Symmetrical 2,7‐disubstituted 9H‐fluoren‐9‐one as a novel and promising scaffold for selective targeting of SIRT2 Archiv der Pharmazie DOI 10.1002/ardp.202400661 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.8%
  9. 2024 Synergistic ferroptosis in triple-negative breast cancer cells: Paclitaxel in combination with Erastin induced oxidative stress and Ferroportin-1 modulation in MDA-MB-231 cells NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY DOI 10.1007/s00210-024-03523-8 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.8%
  10. 2024 Cucurbitacin B and erastin co-treatment synergistically induced ferroptosis in breast cancer cells via altered iron-regulating proteins and lipid peroxidation Toxicology in Vitro DOI 10.1016/j.tiv.2023.105732 YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.8%
  11. 2023 Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells Life Sciences DOI 10.1016/j.lfs.2022.121222 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.0%
  12. 2023 New Flavone Derivatives Targeting BET Proteins in Cancer: Synthesis, Structure Analysis and Investigation of Bromodomain Inhibitory Activities** ChemistrySelect DOI 10.1002/slct.202302492 YÖKSİS SJR Q3 JCR Q3 OpenAlex 47.7%
  13. 2023 Investigation on formulation parameters of donepezil HCl loaded solid lipid nanoparticles Brazilian Journal of Pharmaceutical Sciences DOI 10.1590/s2175-97902023e22330 YÖKSİS SJR Q3 JCR Q4 OpenAlex 68.6%
  14. 2023 Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma Journal of Cancer Research and Clinical Oncology DOI 10.1007/s00432-023-05456-w YÖKSİS SJR Q1 JCR Q3 OpenAlex 79.3%
  15. 2022 Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer Current Medicinal Chemistry DOI 10.2174/0929867328666210810115812 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 96.6%
  16. 2022 Atorvastatin induces downregulation of matrix metalloproteinase-2/9 in MDA-MB-231 triple negative breast cancer cells Medical Oncology DOI 10.1007/s12032-022-01880-z YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.1%
  17. 2022 Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105746 YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.1%
  18. 2022 Box-Behnken design optimization and in vitro cell based evaluation of piroxicam loaded core-shell type hybrid nanocarriers for prostate cancer Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2022.114799 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.6%
  19. 2020 Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2020.119565 YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.0%
  20. 2020 Potentiation of the Effect of Lonidamine by Quercetin in MCF-7 human breast cancer cells through downregulation of MMP-2/9 mRNA Expression Anais da Academia Brasileira de Ciências DOI 10.1590/0001-3765202020200548 YÖKSİS SJR Q1 JCR Q3 OpenAlex 78.8%

Projects 5

  1. 2021 Öncü Bileşik Optimizasyonu ile Yeni Selektif SIRT2 İnhibitörlerinin Geliştirilmesi Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2021-08-26 – 2024-01-26
  2. 2022 Yeni Bazı Karbamat Türevi Bileşiklerin Sentezi, Antiproliferatif ve Histon Deasetilaz-Metalloproteinaz Enzim İnhibitör Aktiviteleri Üzerinde Çalışmalar -Tübitak 1001 · Tamamlandı 2022-03-15 – 2024-12-15
  3. 2021 Paklitaksel'in Çeşitli Meme Kanseri Hücreleri Üzerinde Ferroptotik Etkinliğinin Araştırılması Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2021-07-08 – 2022-07-08
  4. 2018 Yeni Bazı Flavon Türevi Bileşiklerin Sentezi, Antikanser Ve Bromodomain İnhibitör Aktiviteleri Üzerinde Çalışmalar -Tübitak 1001 · Tamamlandı 2018-06-15 – 2021-04-15
  5. 2017 Kukurbitasin B'nin Lipid Polimer Hibrit Nanopartikül Formülasyonlarının Oluşturulması ve İnsan Meme Kanseri Hücrelerindeki Antiproliferatif ve Apoptotik Etki Mekanizmalarının Araştırılması -Tübitak 1001 · Tamamlandı 2017-12-01 – 2019-06-01

Books 1

  1. 2022 Frontiers in Clinical Drug Research – Anti Allergy Agents-5th Volume Bentham Science ISBN 2452-3194 Kitap Bölümü · Bilimsel Kitap

Proceedings 17 See all (17) →

  1. — Brassinin Synergistically Induced Anticancer Effects of Imatinib in SW480 Colon Cancer Cells The 12nd International Symposium on Pharmaceutical Sciences (ISOPS 2018)
  2. 2026 Targeting CNS Tumor Cells With Photodynamic Therapy: Preclinical Evaluation Of A Novel Acridine-Derived NIR-Photosensitizer 9th International Health Sciences and Life Congress
  3. 2025 Reviving the Classics: Venetoclax Sensitizes Lung Cancer Cells to Conventional Chemotherapeutics via Ferroptotic Pathways and DNA damage X. Multidisciplinary Cancer Research Congress
  4. — Cucurbitacin B Loaded Lipid Polymer Hybrid Nanocarriers Induced a Significant Decrease in Mitochondrial Membrane Potential in Breast Cancer Cells HDIR-5, “Translating Science to Medicine:Targets and Therapeutics (2018)
  5. — The Apoptotic Effect of Atorvastatin in MDAMB231 cells is related with down-regulation of MMP-2/9 mRNA Expression Congress of the Croatian Society of Biochemistry and Molecular Biology (HDBMB 2019)

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
17
With an akaturk profile
15
Turkish institutions
4
Co-authored works
%79

Academic co-authors 15

  1. FİLİZ BAKAR ATEŞ Profesör · Ankara Üniversitesi 19
  2. GÖKÇEN EREN Profesör · Gazi Üniversitesi 6
  3. MAHMUT GÖZELLE Doktor Öğretim Üyesi · Gazi Üniversitesi 5
  4. YEŞİM ÖZKAN Profesör · Gazi Üniversitesi 5
  5. SELEN GÖZDE KAYA Araştırma Görevlisi · Gazi Üniversitesi 4
  6. AHMET BUĞRA AKSEL Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 3
  7. HABİBE BEYZA GÜNİNDİ Araştırma Görevlisi · Gazi Üniversitesi 3
  8. ZÜBEYİR ELMAZOĞLU Doçent · Ankara Medipol Üniversitesi same university 3
  9. CEYDA TUBA ŞENGEL TÜRK Profesör · Ankara Üniversitesi 2
  10. ASUMAN BOZKIR Profesör · Ankara Üniversitesi 1
Show all (15)
  1. BERRİN KÜÇÜKTÜRKMEN Doçent · Ankara Üniversitesi 1
  2. FİKRİYE ÖZGENCİL Araştırma Görevlisi · Gazi Üniversitesi 1
  3. GİZEM RÜYA TOPAL Doktor Öğretim Üyesi · Sağlık Bilimleri Üniversitesi 1
  4. OYA BOZDAĞ DÜNDAR Profesör · Ankara Üniversitesi 1
  5. UMUT CAN ÖZ Doçent · Ankara Üniversitesi 1

National collaboration 4 institutions

Within own university3 joint works · Ankara Medipol Üniversitesi

  1. Ankara Üniversitesi 19 works · 6 academics
  2. Gazi Üniversitesi 6 works · 6 academics
  3. Karadeniz Teknik Üniversitesi 3 works · 1 academics
  4. Sağlık Bilimleri Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 2

ALBERTO MASSAROTTI 4IŞILAY GÜLTEKİN

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.